help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guo, J.
Right arrow Articles by McLachlan, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guo, J.
Right arrow Articles by McLachlan, S. M.
The Journal of Clinical Endocrinology & Metabolism Vol. 82, No. 3 925-931
Copyright © 1997 by The Endocrine Society


Experimental Studies

Recombinant Thyroid Peroxidase-Specific Fab Converted to Immunoglobulin G (IgG) Molecules: Evidence for Thyroid Cell Damage by IgG1, but Not IgG4, Autoantibodies1

Jin Guo, Juan Carlos Jaume2, Basil Rapoport and Sandra M. McLachlan

Thyroid Molecular Biology Unit, Veterans Administration Medical Center, and the University of California, San Francisco, California 94121

Address all correspondence and requests for reprints to: Dr. Sandra McLachlan, Veterans Administration Medical Center, Thyroid Molecular Biology Unit (111T), 4150 Clement Street, San Francisco, California 94121.

A recombinant autoantibody Fab (SP1.4) to thyroid peroxidase (TPO), cloned from intrathyroidal B cell immunoglobulin genes, interacts with an epitope on TPO recognized by all patients with autoimmune thyroid disease. To compare the biological properties of IgG1 and IgG4 TPO autoantibodies, we converted Fab SP1.4 to full-length immunoglobulins. The SP1.4 heavy and {kappa} light chain variable region genes, spliced by overlap PCR to a mammalian signal peptide, were transferred to expression vectors for human IgG1, IgG4, and {kappa} L chains. Plasmids containing the IgG1 (or IgG4) heavy chain and the {kappa} L chain were cotransfected into SP2/0 mouse myeloma cells. Cells secreting TPO autoantibodies were cloned, and IgG1-SP and IgG4-SP were affinity purified from medium using protein G. Their subclass specificities were confirmed by enzyme-linked immunosorbent assay and fluorometry after binding to Chinese hamster ovary cells expressing cell surface TPO. Further confirmation of SP1.4 Fab conversion to full-length molecules was the ability of protein A to precipitate IgG1-SP and IgG4-SP complexed to [125I]TPO. IgG1-SP1.4, IgG4-SP1.4, and Fab SP1.4 had similar high affinities for TPO (Kd = ~2 x 10-10 mol/L). Complexes of [125I]TPO and IgG1-SP (but not IgG4-SP) bound to peripheral blood mononuclear cells (PBMC), but not to a B cell line. Flow cytometry demonstrated Fc receptors Fc{gamma}RI, Fc{gamma}RII, and Fc{gamma}RIII on PBMC, but only Fc{gamma}RII on the B cell line. Together, these data indicate that IgG1-SP/TPO complexes bind to either Fc{gamma}RI on monocytes or RIII on natural killer cells. In assays for antibody-dependent cytotoxicity using PBMC, 51Cr release was higher for thyroid cells preincubated with IgG1-SP (13.4%) than with IgG4-SP (2.5%) or with culture medium alone (-0.7%). No specific 51Cr release was observed when either fibroblasts or Chinese hamster ovary cells expressing cell surface TPO were used as target cells.

In conclusion, a human TPO-specific Fab converted to IgG1, but not IgG4, can mediate cytotoxic effects on human thyroid cells in vitro. These observations support the clinical relevance of TPO autoantibody subclass distribution and emphasize the likelihood that, as opposed to being simple markers of thyroid damage, TPO autoantibodies may play a role in the induction of thyroid dysfunction in vivo.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
S. A. Rebuffat, B. Nguyen, B. Robert, F. Castex, and S. Peraldi-Roux
Antithyroperoxidase Antibody-Dependent Cytotoxicity in Autoimmune Thyroid Disease
J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 929 - 934.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C.-R. Chen, G. D. Chazenbalk, K. A. Wawrowsky, S. M. McLachlan, and B. Rapoport
Evidence that Human Thyroid Cells Express Uncleaved, Single-Chain Thyrotropin Receptors on Their Surface
Endocrinology, June 1, 2006; 147(6): 3107 - 3113.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. P. Ng and A. W. C. Kung
Induction of Autoimmune Thyroiditis and Hypothyroidism by Immunization of Immunoactive T Cell Epitope of Thyroid Peroxidase
Endocrinology, June 1, 2006; 147(6): 3085 - 3092.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Guo, S. M. McLachlan, P. N. Pichurin, C.-R. Chen, N. Pham, H. A. Aliesky, C. S. David, and B. Rapoport
Relationship between Thyroid Peroxidase T Cell Epitope Restriction and Antibody Recognition of the Autoantibody Immunodominant Region in Human Leukocyte Antigen DR3 Transgenic Mice
Endocrinology, November 1, 2005; 146(11): 4961 - 4967.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Bresson, M. Pugniere, F. Roquet, S. A. Rebuffat, B. N-Guyen, M. Cerutti, J. Guo, S. M. McLachlan, B. Rapoport, V. Estienne, et al.
Directed Mutagenesis in Region 713-720 of Human Thyroperoxidase Assigns 713KFPED717 Residues as Being Involved in the B Domain of the Discontinuous Immunodominant Region Recognized by Human Autoantibodies
J. Biol. Chem., September 10, 2004; 279(37): 39058 - 39067.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. P. Ng, J. Paul Banga, and A. W. C. Kung
Development of a Murine Model of Autoimmune Thyroiditis Induced with Homologous Mouse Thyroid Peroxidase
Endocrinology, February 1, 2004; 145(2): 809 - 816.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Bresson, M. Cerutti, G. Devauchelle, M. Pugniere, F. Roquet, C. Bes, C. Bossard, T. Chardes, and S. Peraldi-Roux
Localization of the Discontinuous Immunodominant Region Recognized by Human Anti-thyroperoxidase Autoantibodies in Autoimmune Thyroid Diseases
J. Biol. Chem., March 7, 2003; 278(11): 9560 - 9569.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Guo, S. M. McLachlan, and B. Rapoport
Localization of the Thyroid Peroxidase Autoantibody Immunodominant Region to a Junctional Region Containing Portions of the Domains Homologous to Complement Control Protein and Myeloperoxidase
J. Biol. Chem., October 18, 2002; 277(43): 40189 - 40195.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Guo, X.-M. Yan, S. M. McLachlan, and B. Rapoport
Search for the Autoantibody Immunodominant Region on Thyroid Peroxidase: Epitopic Footprinting with a Human Monoclonal Autoantibody Locates a Facet on the Native Antigen Containing a Highly Conformational Epitope
J. Immunol., January 15, 2001; 166(2): 1327 - 1333.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. S. McIntosh, M. S. Asghar, E. H. Kemp, P. F. Watson, A. Gardas, J. P. Banga, and A. P. Weetman
Analysis of Immunoglobulin G{kappa} Antithyroid Peroxidase Antibodies from Different Tissues in Hashimoto's Thyroiditis
J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3818 - 3825.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society